Nrdp1-mediated degradation of BRUCE decreases cell viability and induces apoptosis in human 786-O renal cell carcinoma cells
Open Access
- 18 May 2016
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 12 (2) , 597-602
Abstract
Neuregulin receptor degradation protein-1 (Nrdp1) is involved in a plethora of cellular processes and plays an essential role in the development and progression of human cancers. However, its role in renal cell carcinoma (RCC) remains unclear. Therefore, the present study aimed to explore the biological significance of Nrdp1 in RCC. Western blot analyses of tissue samples from 24 patients with primary RCC revealed lower Nrdp1 and higher baculovirus inhibitor of apoptosis repeat‑containing ubiquitin‑conjugating enzyme (BRUCE) protein levels in RCC tissues compared with adjacent normal tissues. In addition, MTT and apoptosis assays demonstrated that Nrdp1 overexpression resulted in decreased cell viability and enhanced apoptosis in RCC 786‑O cells; conversely, Nrdp1 knockdown increased 786‑O cell viability and inhibited apoptosis. Further analysis showed that BRUCE downregulation partially attenuated the effects of Nrdp1 knockdown on RCC cell viability and apoptosis. Moreover, an inverse association was obtained between BRUCE and Nrdp1 protein levels. These findings suggest that Nrdp1‑mediated degradation of BRUCE decreases cell viability and induces apoptosis in RCC cells, highlighting Nrdp1 as a potential target for RCC treatment.Keywords
This publication has 27 references indexed in Scilit:
- Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and FutureSeminars in Oncology, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- Structure‐based mutagenesis of the substrate‐recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3Protein Science, 2007
- Loss of Nrdp1 Enhances ErbB2/ErbB3–Dependent Breast Tumor Cell GrowthCancer Research, 2006
- The Membrane-associated Inhibitor of Apoptosis Protein, BRUCE/Apollon, Antagonizes Both the Precursor and Mature Forms of Smac and Caspase-9Journal of Biological Chemistry, 2005
- Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection functionNature Cell Biology, 2004
- Dual Role of BRUCE as an Antiapoptotic IAP and a Chimeric E2/E3 Ubiquitin LigaseMolecular Cell, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A Human IAP-Family Gene, Apollon, Expressed in Human Brain Cancer CellsBiochemical and Biophysical Research Communications, 1999